Two more clinical trials go against Lilly
In the midst of Eli Lilly and Co.’s surprisingly positive news about its experimental Alzheimer’s drug, the company suffered two other setbacks with former stars of its pipeline.
Home » Search
Search Results
4,410 results for '\"eli lilly\"'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
People
Dr. Amanda Beach, a pediatrician, has joined St. Vincent Medical Group in Carmel. She earned a bachelor’s degree from the University of Dayton in Ohio and her medical degree from the Loyola Stritch School of Medicine in Chicago. She completed her pediatric residency at Riley Hospital for Children at Indiana University Health.
The School of Science at IUPUI has hired Steve Pressé as an assistant professor of physics. Pressé recently completed a fellowship in biophysics at the University of California at San Francisco. Pressé earned a bachelor’s degree from McGill University in Canada and earned his doctorate in chemical physics at the Massachusetts Institute of Technology.
OrthoWorx, the Warsaw-based orthopedics business development group, named Sheryl Conley its next CEO, replacing David Floyd, who plans to return to a position in the orthopedic industry. Conley is a 25-year veteran of Warsaw-based Zimmer Holdings Inc., where she was most recently chief marketing officer. She earned a bachelor’s degree in biology and chemistry as well as a master’s in business administration from Ball State University.
Eli Lilly and Co. announced that Michael Harrington will become its general counsel on Jan. 1, replacing Bob Armitage, who will retire at the end of this year. Harrington is Lilly’s deputy general counsel, overseeing legal matters at Lilly’s five business units. He earned his law degree from Columbia University and joined Lilly in 1991. Armitage joined Lilly in 1999 as general patent counsel for Lilly Research Laboratories. He has been the company’s general counsel for the past decade.
Anesthesia Consultants of Indianapolis LLC added three new physicians in July. Dr. John Gripe and Dr. Evan Miller both did their medical training at the Indiana University School of Medicine. Dr. Lindsey Hansen earned her medical degree at St. George’s University School of Medicine.
Lilly’s Alimta fails to extend survival in lung cancer study
Eli Lilly and Co. said Thursday that its cancer drug Alimta didn’t extend overall survival when combined with Roche Holding AG’s Avastin in patients with a form of lung tumor.
Eli Lilly aims to ramp up social media presence
The drugmaker recently drafted social media guidelines it hopes can help it expand its use of social media to more of its employees—without running afoul of regulators.
FDA drug-review deal may unravel as fiscal cliff looms
A $6.4 billion accord for U.S. drug and medical-device reviews is set to unravel just three months after taking effect as lawmakers squabble over budget cutbacks.
Marian University restoring velodrome to former glory
Marian University has sunk $350,000 so far into restoring the Major Taylor Velodrome near its campus, and has plans for much more.
Study: Indiana tax code discourages small businesses
A new study of Indiana's business tax structure suggests the state's tax code discourages the small, home-grown businesses often considered the engines of job creation.
Ten drugmakers team up to improve testing process
Pharmaceutical industry heavyweights, including Eli Lilly and Co., are teaming up to improve the way experimental drugs are tested so they can get approved, and reach patients, faster.
Appreciating White River
Both in business and at home, water is so much a part of our daily lives that we often take it for granted.
Lilly’s Cialis gets European endorsement for new use
A European committee has endorsed the use of Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate.
Lilly competitor Novo investing $100M in China
Novo Nordisk A/S, the world’s largest insulin maker, plans to spend $100 million on research in China. The move follows a similar one by Indianapolis-based Eli Lilly, which opened a 150-person research center in Shanghai in May.
Group aims to cut costs of late-stage drugs
You know things are bad in the fiercely competitive pharma industry when drugmakers start turning to each other for help. But that’s exactly what happened last week when 10 major drug companies—including Eli Lilly and Co.—joined forces to cut costs out of clinical trials.
People
Dr. Kristina Whitesell, a pediatrician, has established a practice with Franciscan Physician Network Heartland Crossing Pediatrics in Camby. Whitesell earned her medical degree at Washington University School of Medicine in St. Louis and also earned a bachelor’s degree in biochemistry from Gustavus Adolphus College in Minnesota.
Indianapolis law firm Hall, Render, Killian, Heath & Lyman has hired attorney Janelle McIntyre as part of its Indianapolis litigation group. McIntyre completed her undergraduate studies at Indiana University and earned her law degree at IU McKinney School of Law.After nearly 30 years as an attorney at Indianapolis law firm Riley, Bennett & Egloff, Mary Reeder has accepted a position as in-house general counsel at Reid Hospital & Health Care Services in Richmond.
Victor Vinci has joined Bloomington-based Cook Pharmica as chief scientific officer. Prior to joining Cook, Vinci worked many years at Eli Lilly and Co. in Indianapolis. He also spent six years at Merck & Co. Inc. He holds a master’s degree and a doctorate in microbiology from The Ohio State University. He also holds a bachelor’s degree in chemistry and microbiology from Bowling Green State University.
Company news
A Cicero-based developer has won city approval to build a $15.7 million senior health care center at 16th Street and Arlington Avenue on Indianapolis’ east side. The city’s Metropolitan Development Commission gave its blessing Sept. 19 after accepting an offer from Mainstreet Property Group LLC to purchase the property for $912,500. The city bought the nine-acre parcel from the federal government for $1 in September 2004. It had been used by Raytheon Technical Services Co. LLC. Nearly half of the project’s cost could be financed by $7.4 million in city-issued bonds. Mainstreet’s plans for the center call for 70 skilled-nursing and 30 assisted-living beds. The facility is expected to create up to 150 jobs, Mainstreet officials said. The project would be Mainstreet’s first newly constructed facility in Marion County. In 2006, it purchased out of bankruptcy the Highland Health and Living Center in Indianapolis at 2926 N. Capitol Ave. The company owns or co-owns 13 senior health care centers in Indiana, Illinois and Ohio, and has six more under development. It plans to break ground on up to 12 centers by the end of the year, including a $13.3 million facility in Westfield.
A European Union committee has endorsed the use of Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate, according to the Associated Press. The EU’s Committee for Medicinal Products for Human Use recommended approval of Cialis for benign prostatic hyperplasia. The condition often comes with such symptoms as the need to urinate urgently and frequently. The European Commission usually decides on the committee's opinion within a month or two, Lilly said Friday. The Commission is not required to adopt the committee recommendation, but it usually does. The U.S. Food and Drug Administration approved Cialis last fall for the treatment of symptoms of an enlarged prostate. Regulators also have approved the use in Canada, Mexico and Brazil, among other countries. Cialis brought in $1.88 billion last year. Its patents will last until 2017.
Indiana’s adult obesity rate is predicted to climb from 25 percent now to 56 percent by 2030, according to new projections released by the Trust for America’s Health and the Robert Wood Johnson Foundation. That shocking increase would move Indiana from the 38th-most-obese state now to the 26th-most-obese state. Mississippi is predicted to lead the nation in obesity in 2030, as it does now. And even Colorado, which has the least obese population—with only 21 percent obese—is predicted to have 45 percent of its adults obese in 2030. The report, titled "F as in Fat,” was released on Sept. 18. “This study shows us two futures for America’s health,” said Dr. Risa Lavizzo-Mourey CEO of the New Jersey-based Robert Wood Johnson Foundation. "At every level of government, we must pursue policies that preserve health, prevent disease and reduce health care costs. Nothing less is acceptable.”
State drug fraud cases on the rise, study says
Federal and state prosecutors have collected more than $30 billion from drug companies for alleged fraud and illegal marketing over the last 20 years, according to a new report by consumer advocacy group Public Citizen.
Symphony donors question giving amid contract dispute
The ailing Indianapolis Symphony Orchestra intends to step up annual donations 40 percent. But many longtime donors feel conflicted about future contributions as they await word on whether the ISO will scale back to part time.
RACE: Is CityWay a mixed-use project or urban neighborhood?
CityWay’s design does a lot of things well. Its site plan is woven into the Indy grid, providing active street edges.